COENZYME Q10 DEFICIENCY, PRIMARY, 3
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.700 |
None |
1.000 |
4 |
3
|
2006 |
2016 |
Daytime somnolence
|
phenotype |
|
Sign or Symptom
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Heavy proteinuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
EEG with focal spikes
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Middle insomnia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Undetectable visual evoked potentials
|
phenotype |
|
Finding
|
6
|
1
|
0.100 |
None |
|
0 |
|
|
|
Severe lactic acidosis
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
8
|
1
|
0.100 |
None |
|
0 |
|
|
|
Collapsing glomerulopathy
|
disease |
|
Disease or Syndrome
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Edema, generalized
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Cardiovascular Diseases
|
Pathologic Function
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Generalized Edema, CTCAE
|
phenotype |
|
Finding
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
COENZYME Q10 DEFICIENCY
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
21
|
3
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2018 |
Diffuse mesangial sclerosis (disorder)
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
22
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Familial hematuria
|
disease |
|
Disease or Syndrome
|
23
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Generalized tonic-clonic seizures with focal onset
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
23
|
1
|
0.100 |
None |
|
0 |
|
|
|
Nocturia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
28
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Gastrostomy tube feeding in infancy
|
phenotype |
|
Finding
|
38
|
19
|
0.100 |
None |
|
0 |
|
|
|
Anasarca
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
41
|
|
0.100 |
None |
|
0 |
|
|
|
Akinesia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
43
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Episodic vomiting
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
43
|
10
|
0.100 |
None |
|
0 |
|
|
|
Hereditary Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
45
|
12
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
REM Sleep Behavior Disorder
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
46
|
16
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Parkinson Disease, Familial, Type 1
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
46
|
27
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Excessive daytime sleepiness
|
phenotype |
|
Sign or Symptom
|
46
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Focal T2 hyperintense basal ganglia lesion
|
phenotype |
|
Finding
|
46
|
3
|
0.100 |
None |
|
0 |
|
|
|
Calcification of coronary artery
|
phenotype |
Nutritional and Metabolic Diseases; Cardiovascular Diseases
|
Pathologic Function
|
51
|
205
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |